Against the Resilience of High-Grade Gliomas: The Immunotherapeutic Approach (Part I)

The resilience of high-grade gliomas (HGGs) against conventional chemotherapies is due to their heterogeneous genetic landscape, adaptive phenotypic changes, and immune escape mechanisms. Innovative immunotherapies have been developed to counteract the immunosuppressive capability of gliomas. Nevert...

Descripción completa

Detalles Bibliográficos
Autores principales: Giotta Lucifero, Alice, Luzzi, Sabino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003180/
https://www.ncbi.nlm.nih.gov/pubmed/33803885
http://dx.doi.org/10.3390/brainsci11030386